Baxter
BAX
#1124
Rank
A$26.07 B
Marketcap
$51.06
Share price
0.67%
Change (1 day)
-6.86%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

P/S ratio for Baxter (BAX)

P/S ratio as of November 2024 (TTM): 1.14

According to Baxter's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.21. At the end of 2024 the company had a P/S ratio of 1.14.

P/S ratio history for Baxter from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.14-14.16%
20231.32-23.75%
20221.74-48.35%
20213.36-4.25%
20203.51-5.74%
20193.7322.69%
20183.04-8.95%
20173.3340.52%
20162.3713.22%
20152.10-19.94%
20142.625.33%
20132.49-3.13%
20122.5727.77%
20112.01-12.26%
20102.29-18.46%
20092.814.3%
20082.69-17.69%
20073.2712.46%
20062.9121.72%
20052.396.43%
20042.246.73%
20032.100.67%
20022.09-50.16%
20014.19

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
0.1306-88.52%๐Ÿ‡บ๐Ÿ‡ธ USA
6.68 487.17%๐Ÿ‡บ๐Ÿ‡ธ USA
8.72 666.70%๐Ÿ‡บ๐Ÿ‡ธ USA
3.27 187.29%๐Ÿ‡บ๐Ÿ‡ธ USA
6.58 478.43%๐Ÿ‡บ๐Ÿ‡ธ USA
4.64 308.24%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
0.0919-91.92%๐Ÿ‡บ๐Ÿ‡ธ USA
3.38 197.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
1.79 57.82%๐Ÿ‡บ๐Ÿ‡ธ USA